For Immediate Release
Vantage Oncology Announces Joint Venture with Valley Radiotherapy Associates Medical Group to Form Holy Cross Radiation Therapy Center - Cancer Center Offers Patients Convenient Access to the Most Advanced Radiation Therapy Treatments

MISSION HILLS, Calif. (September 12, 2012) – In its continued efforts to provide innovative radiation therapy treatment to cancer patients in the Los Angeles County, Vantage Oncology, a Manhattan Beach, Calif.-based developer and operator of state-of-the-art radiation oncology centers, has announced a joint venture with Valley Radiotherapy Associates Medical Group, Inc. (VRA) to form Holy Cross Radiation Therapy Center. The facility is located at 15031 Rinaldi Street, Mission Hills, CA 91345. The center opened under VRA/Vantage Oncology management on Monday, September 4, 2012.

(CONT'D)As part of the joint venture agreement, Vantage Oncology will provide operations management and funding for facility and technology upgrades to support the center’s efforts to provide academic quality cancer care in a patient-friendly environment.

“The joint venture between Valley Radiotherapy Associates and Vantage Oncology will provide local patients access to state-of-the-art diagnostic and radiation therapy services,” said Michael T. Fiore, CEO of Vantage Oncology. “In combination with the extensive expertise of the physicians and clinical staff, I am confident that our team of experts will become a vital and highly regarded cancer treatment resource for patients in Mission Hills and the surrounding communities.”

The Center’s radiation oncology services will be spearheaded by a highly trained and experienced clinical team of board certified Radiation Oncologists. Medical Director Nancy A. Ellerbroek, MD, FASTRO, FACR brings extensive clinical expertise, research, and familiarity with the community. Robert Zimmerman, MD, medical director at the Santa Clarita Radiation Therapy Center and Lauren VanderSpek, MD, will also practice at this center.

“Our mission is to deliver personalized care to each and every patient,” said Dr. Ellerbroek. “With our state-of-the-art facilities and a team of highly-trained radiation therapists, oncology nurse, and other support staff, I am confident that our center will provide the most comprehensive treatment and compassionate care in the Mission Hills area.”

Patients will also have access to today’s most advanced and clinically proven radiotherapy technologies. The center boasts innovative technologies including CT Simulation for imaging and planning, Varian RapidArc™, Intensity Modulated and Image-Guided Radiation Therapy (IMRT/IGRT).

“With our multi-disciplinary approach to treating malignancies today, our technology and our evidence-based treatment protocols, we design our treatments with the goal of superior outcomes for our patients. Varian RapidArc™ offers more efficient delivery of radiation treatment and enables us to deliver higher, more effective doses of radiation with fewer complications and side effects,” added Dr. Ellerbroek. “We are also pleased to have the assistance of our Nurse Navigator Tricia Eugenio, RN, OCN who assists patients through the treatment process. Our goal is to provide not only highly precise and accurate treatment but also patient-centered care.”

For more information about Holy Cross Radiation Therapy Center and to schedule an appointment, please call (818) 496-4410 or visit

About Valley Radiotherapy Associates Medical Group, Inc.
Valley Radiotherapy Associates Medical Group, Inc. (VRA) of Manhattan Beach, California, was founded by Leslie E. Botnick, M.D., and Christopher M. Rose, M.D., in June, 1983 to deliver radiation oncology services. Today, VRA Medical Group has 34 board-certified radiation oncologists and provides advanced radiation therapy services to communities at 17 hospitals and freestanding centers in Los Angeles, Orange, Riverside, Imperial Valley and San Bernardino Counties in California and Denver, Colorado. VRA has distinguished itself during the past 25 years as one of the premier radiation oncology groups in the nation with a proven record of excellence in clinical treatment, superiority in service delivery and technical acumen to develop new cancer treatment programs. For more information about VRA, visit

About Vantage Oncology
Founded in October 2002, Manhattan Beach, California-based Vantage Oncology, LLC, develops and operates radiation oncology centers of excellence through acquisitions and joint ventures. The company’s founding principals was to address the growing need among cancer patients, hospitals and physicians for easily accessible and advanced radiation treatment therapies. Vantage Oncology currently operates 46 treatment facilities in 13 states. Vantage Oncology is led by a seasoned management team including Chief Executive Officer and Co-Founder Michael Fiore, Chief Medical Officer and Co-Founder, Leslie Botnick, M.D., Chief Financial Officer Marshal Salomon and Chief Development Officer Mark Ahern. For more information about Vantage Oncology, visit

# # #

CONTACT: Trace Longo
Longo Communications
(949) 364-2821

Suzanne Gutterman
Network Development Manager
Holy Cross Radiation Therapy Center
(818) 884-1683